Literature DB >> 21604026

[Reimbursement. Case report: Medical implication as precondition for reimbursement by German health insurance on the example of HRpQCT diagnosis of osteoporosis].

S Weber-Endress1, R Nothaas.   

Abstract

The main condition that has to be met for reimbursement is the medical implication of the chosen method. This issue is discussed based on the case of a 72-year-old patient suffering from osteoporotic fractures of the spine. Drug treatment of osteoporosis was observed with a high-resolution peripheral CT (HR-pQCT/XtremeCT). A German court came to the conclusion that there is no added value of the procedure in comparison with the well-established DXA. Judges rejected the need for reimbursement in that particular case and ruled in favor of the insurance company, which had originally refused the refund.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604026     DOI: 10.1007/s00113-011-2046-2

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  8 in total

1.  Predictive value of bone mineral density and morphology determined by peripheral quantitative computed tomography for cancellous bone strength of the proximal femur.

Authors:  N J Wachter; P Augat; M Mentzel; M R Sarkar; G D Krischak; L Kinzl; L E Claes
Journal:  Bone       Date:  2001-01       Impact factor: 4.398

Review 2.  [Radiological diagnosis of osteoporosis].

Authors:  A S Issever; T M Link
Journal:  Radiologe       Date:  2010-05       Impact factor: 0.635

Review 3.  Clinical utility of microarchitecture measurements of trabecular bone.

Authors:  Julio Carballido-Gamio; Sharmila Majumdar
Journal:  Curr Osteoporos Rep       Date:  2006-06       Impact factor: 5.096

4.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

5.  Assessment of trabecular bone structure using MDCT: comparison of 64- and 320-slice CT using HR-pQCT as the reference standard.

Authors:  Ahi S Issever; Thomas M Link; Marie Kentenich; Patrik Rogalla; Andrew J Burghardt; Galateia J Kazakia; Sharmila Majumdar; Gerd Diederichs
Journal:  Eur Radiol       Date:  2009-08-27       Impact factor: 5.315

6.  Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy.

Authors:  A Cohen; D W Dempster; R Müller; X E Guo; T L Nickolas; X S Liu; X H Zhang; A J Wirth; G H van Lenthe; T Kohler; D J McMahon; H Zhou; M R Rubin; J P Bilezikian; J M Lappe; R R Recker; E Shane
Journal:  Osteoporos Int       Date:  2009-05-20       Impact factor: 4.507

7.  Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.

Authors:  Yebin Jiang; Jenny J Zhao; Bruce H Mitlak; Ouhong Wang; Harry K Genant; Erik F Eriksen
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

8.  Measurement of trabecular bone microstructure does not improve prediction of mechanical failure loads at the distal radius compared with bone mass alone.

Authors:  E-M Lochmüller; J Kristin; M Matsuura; V Kuhn; M Hudelmaier; T M Link; F Eckstein
Journal:  Calcif Tissue Int       Date:  2008-10-04       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.